首页> 外文学位 >Studies in organic synthesis: Vitamin D analogs, trioxane dimers and enantioselective selenenylations and [2,3]-sigmatropic rearrangements.
【24h】

Studies in organic synthesis: Vitamin D analogs, trioxane dimers and enantioselective selenenylations and [2,3]-sigmatropic rearrangements.

机译:有机合成方面的研究:维生素D类似物,三恶烷二聚体和对映选择性硒基化和[2,3]-σ重排。

获取原文
获取原文并翻译 | 示例

摘要

Vitamin D plays an essential role in human health through the regulation and absorption of calcium and phosphate, and more importantly cell differentiation, Kra immunology and the regulation of gene transcription. As vitamin D has become more understood within the scientific community the value of this hormone has been recognized, and focus has been on the development of new analogs of 1alpha,25-dihydroxyvitamin D for treatment of diseases such as psoriasis, osteoporosis, and a large variety of cancers. However, due to the calcemic nature of the natural hormone, the challenge in synthesizing alternate analogs is to find the optimal balance between the desired antiproliferative properties of the analog and low calcemic activity. Within this thesis, a variety of different analogs have been synthesized, including novel 16-ene-20-epi analogs, novel 1-deoxy analogs designed as prodrugs to be activated in vivo, and a 24-oxa analog designed to inhibit catabolic degradation. Some of these analogs exhibited desireable antiproliferative properties.;In addition to biologically active vitamin D analogs, a several different series of antimalarial trioxane dimers have been prepared. Malaria is one of the most infectious diseases in the world, infecting 250-300 million people worldwide per year. Of those infected over 3 million people lose their life to this devastating disease, with the majority of those deaths being children under the age of five. These statistics make finding a treatment and cure for malaria of the utmost importance. The challenge for developing new antimalarial treatment lies in fighting the spread of resistance to current chemotherapies as well as gaining the resources for the administration of new treatments in economically underdeveloped countries, which are most affected by the disease.;Artemisinin based chemotherapies have become the first line treatment against malaria because until recently, no parasite resistance has been reported. While artemisinin is highly potent against malaria, the natural product has poor water and oil solubility, making it difficult to be absorbed into the system. It is this challenge that has led to the development of more efficacious artemisinin based analogs to treat malaria. Through the use of carbon based linkers, dimers of artemisinin have been prepared with various functionalities, including ketals, hydrazones, oximes, and beta-hydroxy or beta-fluoro sulfones with the intent of optimizing the bioavailabilty of the compounds, making them more efficacious aganst malaria. Several novel dimers of artemisinin were curative at oral doses of 3 x 30 mg/kg, and some increased the lives of infected mice upon oral dosage of 3 x 10 mg/kg.;Finally, an efficient and enantiocontrolled 3-step synthesis of alphaa-hydroxy-( E)-beta13,gamma7-unsaturated esters has been designed utilizing asymmetric, organocatalytic selenium chemistry. Enantioenriched alpha-selenyl aldehydes, prepared in one step by asymmetric, organocatalytic alpha-selenyation of aldehydes, were directly subjected to a Wittig reaction followed by allylic selenide to selenoxide oxidation and final spontaneous [2,3]-sigmatropic rearrangement to yield the target compounds in 43-65 % overall yield and in 94-97% ee.
机译:维生素D通过调节和吸收钙和磷酸盐,更重要的是细胞分化,Kra免疫学和基因转录的调节,对人类健康起着至关重要的作用。随着科学界对维生素D的了解越来越多,这种激素的价值得到了公认,并且重点一直放在开发用于治疗牛皮癣,骨质疏松和大面积疾病等疾病的1alpha,25-dihydroxyvitamin D的新类似物上。各种癌症。然而,由于天然激素的钙的性质,合成替代类似物的挑战是要在所需的类似物的抗增殖特性和低钙活性之间找到最佳平衡。在本论文中,已经合成了多种不同的类似物,包括新颖的16-ene-20-epi类似物,被设计为要在体内被激活的前药的新颖的1-脱氧类似物以及被设计为抑制分解代谢的24-oxa类似物。这些类似物中的一些表现出令人满意的抗增殖特性。除了具有生物活性的维生素D类似物之外,还制备了几种不同系列的抗疟疾三恶烷二聚体。疟疾是世界上最传染的疾病之一,每年全世界感染250-300百万人。在受感染的人中,有超过300万人死于这种毁灭性的疾病,其中大多数死亡是5岁以下的儿童。这些统计数据使寻找治疗和治愈疟疾的工作极为重要。开发新的抗疟疾疗法的挑战在于对抗对当前化学疗法的耐药性的蔓延,以及在受疾病影响最严重的经济欠发达国家中获得用于管理新疗法的资源。基于青蒿素的化学疗法已成为第一个一线治疗疟疾的方法,因为直到最近,还没有寄生虫抵抗的报道。虽然青蒿素对疟疾具有很强的效力,但天然产物的水和油溶解度很差,因此很难被吸收到系统中。正是这一挑战导致了开发更有效的基于青蒿素的类似物来治疗疟疾。通过使用基于碳的接头,青蒿素的二聚体具有各种功能,包括缩酮,,肟和β-羟基或β-氟砜,目的是优化化合物的生物利用度,使其更有效疟疾。青蒿素的几种新型二聚体在口服剂量为3 x 30 mg / kg时可治愈,而在口服剂量为3 x 10 mg / kg时,某些二聚体可增加感染小鼠的寿命。最后,αa的有效且对映体控制的三步合成已经利用不对称的有机催化硒化学方法设计了-羟基-(E)-β13,γ7-不饱和酯。通过一步反应,通过不对称的有机催化醛的α-硒化制备的对映体富集的α-硒烯醛,直接经过Wittig反应,然后烯丙基亚硒酸酯氧化亚硒酸酯并最终自发地[2,3]-σ重排,得到目标化合物总产率为43-65%,ee为94-97%。

著录项

  • 作者

    Hess, Lindsay Catherine.;

  • 作者单位

    The Johns Hopkins University.;

  • 授予单位 The Johns Hopkins University.;
  • 学科 Chemistry Organic.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 228 p.
  • 总页数 228
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号